2201 Peri-operative chemotherapy ± bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948). (September 2015) - Cunningham, D.; Smyth, E.; Stenning, S.; Stevenson, L.; Robb, C.; Allum, W.; Grabsch, H.; Alderson, D.; Riddell, A.; Chua, S.; Crosby, T.; Mason, R.; et al.